Pasteurellaceae Infections: Clinical Trials

21 trials for Pasteurellaceae Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

18 completed, 3 unknown. 21 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 421Completed 18, Unknown 3

Follow Pasteurellaceae Infections: new trials by email Literature Review of Pasteurellaceae Infections trials Research Report on Pasteurellaceae Infections

Trials (filtered) newest first · largest first

All 21 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Immunogenicity of H. Influenzae Type b PRP-OMP Vaccines in American Indian and Alaska Native Children (the HibVax Study)
Vaxelis, PedvaxHIB - Haemophilus Influenzae Type B Infection
Phase 4CompletedJohns Hopkins Bloomberg School of Public Health3332022-01-272024-06-24
A Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK)'s Infanrix Hexa Vaccine (DTPa-HBV-IPV/Hib) Versus MCM Vaccine BV's Vaxelis Vaccine (DTaP5-HBV-IPV-Hib) in Healthy Infants and Toddlers
DTPa-HBV-IPV/Hib, DTaP5-HBV-IPV-Hib, Pneumococcal 13-valent conjugate vaccine - Diphtheria
Phase 4CompletedGlaxoSmithKline5002021-05-262024-08-27
A Phase IV Study to Assess the Safety of EupentaTM Inj
Eupenta Inj. - Hepatitis B, Diphtheria
Phase 4UnknownLG Chem30002019-09-232019-08-14
Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery
Infanrix hexa - Diphtheria, Hepatitis B
Phase 4CompletedGlaxoSmithKline5512016-09-192020-01-14
Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age
Meningococcal polysaccharide diphtheria toxoid conjugate, Meningococcal polysaccharide diphtheria toxoid conjugate + Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate - Meningitis, Meningococcal Infection
Phase 4CompletedSanofi Pasteur, a Sanofi Company13942012-07-012015-12-15
Safety of Haemophilus Influenza Type b Vaccine When Administered to Korean Children
Haemophilus influenza type b conjugate vaccine - Haemophilus Influenzae Type B Infection
Phase 4CompletedNovartis Vaccines7642011-08-012016-12-01
Study to Evaluate Antibody Persistence in Children Previously Vaccinated With Infanrix Hexa™ or Infanrix-IPV/Hib™
Blood Sampling - Tetanus, Poliomyelitis
Phase 4CompletedGlaxoSmithKline582011-05-302021-01-19
Study to Assess if Quinvaxem Can be Interchanged With Other Pentavalent Vaccines During Standard Childhood Vaccination
Quinvaxem, Quinvaxem/Tritanrix - Diphtheria, Pertussis
Phase 4CompletedCrucell Holland BV4002011-05-012013-09-09
Safety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination Vaccine
Shan 5 - Diphtheria, Tetanus
Phase 4UnknownShantha Biotechnics Limited30002009-01-012009-05-06
Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants
Infanrix™ hexa - Hepatitis B, Tetanus
Phase 4CompletedGlaxoSmithKline2242008-09-232019-11-27
Safety and Immunogenicity Study of a Liquid Pentavalent Combination Vaccine
Shan5 - Diphtheria, Tetanus
Phase 4CompletedShantha Biotechnics Limited1602008-03-012009-06-25
Phase IV Interchangeability Study of a Liquid Pentavalent Combination Vaccine
Shan 5, Easy Five - Diphtheria, Tetanus
Phase 4CompletedShantha Biotechnics Limited1442008-03-012009-06-25
Middle Meatal Bacteriology During Acute Respiratory Infection in Children
placebo, amoxicillin clavulanate acid - Acute Respiratory Infection, Sinusitis
Phase 4UnknownOulu University Hospital1202007-11-012007-10-19
Study of Long-term Antibody Persistence After a Booster Dose of Menitorix Vaccine
Menitorix, Infanrix IPV - Haemophilus Influenzae Type b, Neisseria Meningitidis
Phase 4CompletedGlaxoSmithKline2882007-05-162020-06-16
Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in Thailand
Diphtheria, Tetanus, Polio, Acellular Pertussis and Hib Vac - Diphtheria, Tetanus
Phase 4CompletedSanofi1862005-12-012012-04-16
Assess the Safety & Reactogenicity of DTPa-IPV/Hib Vaccine Administered at 3, 4, 5 & 18 Mths of Age, in Healthy Infants
GSK Biologicals' combined DTPa-IPV/Hib vaccine - Diphtheria, Tetanus
Phase 4CompletedGlaxoSmithKline25902004-11-022020-01-02
Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™
Diphtheria and Tetanus Toxoids and Acellular Pertussis (DAPTACEL®) - Diphtheria, Tetanus
Phase 4CompletedSanofi Pasteur, a Sanofi Company9892004-02-012016-04-14
Assessment of the Immunogenicity and Safety of PENTAXIM™ in Philippines
Diphteria, Tetanus, Polio, Acellular Pertussis, Hib vaccine - Diphtheria, Tetanus
Phase 4CompletedSanofi3872003-10-012012-04-16
Comparison of Immunogenicity and Reactogenicity of INFANRIX™ HEXA and HEXAVAC™ Vaccines as a Primary Vaccination Course
DTPa-HBV-IPV/Hib Vaccine (INFANRIX™ HEXA), DTPa-HBV-IPV-Hib vaccine (HEXAVAC™) - Hepatitis B, Poliomyelitis
Phase 4CompletedGlaxoSmithKline4942003-10-012016-08-05
The Immediate and Longterm Immune Responses of UK Infants and Young Children to a Booster Dose of Hib Vaccine
Hib conjugate vaccine - Haemophilus Influenzae Type b
Phase 4CompletedPublic Health England2003-04-012018-08-24

Showing 20 of 21. Sign in to see all of them.

Narrower conditions

Haemophilus Infections (21)  ·  Diphtheria (15)  ·  Tetanus (15)  ·  Hepatitis B (10)  ·  Whooping Cough (10)  ·  Poliomyelitis (8)  ·  Meningitis (1)  ·  Meningococcal Infections (1)  ·  Respiratory Tract Infections (1)  ·  Rhinosinusitis (1)  ·  Sinusitis (1)  ·  Virus Diseases (1)

Broader conditions

Bacterial Infections (21)  ·  Bacterial Infections and Mycoses (21)  ·  Gram-Negative Bacterial Infections (21)  ·  Infections (21)  ·  Actinomycetales Infections (15)  ·  Clostridium Infections (15)  ·  Corynebacterium Infections (15)  ·  Gram-Positive Bacterial Infections (15)  ·  Virus Diseases (13)  ·  Respiratory Tract Diseases (11)  ·  Blood-Borne Infections (10)  ·  Bordetella Infections (10)  ·  Communicable Diseases (10)  ·  DNA Virus Infections (10)

Interventions

Tetanus Toxoid (4)  ·  Pentavac (2)  ·  Vaxelis (2)  ·  diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine (2)  ·  13-valent pneumococcal vaccine (1)  ·  Blood Specimen Collection (1)  ·  Diphtheria-Tetanus-acellular Pertussis Vaccines (1)  ·  Haemophilus influenzae-type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine (1)  ·  Hexavac (1)  ·  HibTITER protein, Haemophilus influenzae (1)  ·  Meningococcal Vaccines (1)  ·  Methods (1)  ·  pentacel (1)

Sponsors

GlaxoSmithKline (7)  ·  Shantha Biotechnics Limited (3)  ·  Sanofi (2)  ·  Sanofi Pasteur, a Sanofi Company (2)  ·  Centers for Disease Control and Prevention (1)  ·  Crucell Holland BV (1)  ·  Johns Hopkins Bloomberg School of Public Health (1)  ·  LG Chem (1)  ·  Novartis Vaccines (1)  ·  Oulu University Hospital (1)  ·  Public Health England (1)

Countries

United States (4)  ·  Finland (3)  ·  India (3)  ·  Italy (3)  ·  Canada (2)  ·  Philippines (2)  ·  Spain (2)  ·  Sweden (2)  ·  Australia (1)  ·  Czechia (1)  ·  Germany (1)  ·  Norway (1)  ·  Poland (1)  ·  Puerto Rico (1)  ·  Singapore (1)

Top investigators

Raman Rao, MD (3)  ·  Aila Kristo, MD (1)  ·  Anna Marttila, MD (1)  ·  Elizabeth Miller, MBBS FRCPath (1)  ·  Jukka-Pekka Kuusiniemi, MD (1)  ·  Laura Hammitt, MD (1)  ·  Maria RZ Capeding, MD (1)  ·  Olli-Pekka Alho, professor (1)  ·  Thomas W Hennessy, MD,MPH (1)  ·  Ulla Lantto, MD (1)

Results publications

PMID 17699835, PMID 24176498, PMID 33612341

NIH funding

2014 (1), 2015 (1), 2019 (1)